This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Mettler-Toledo (MTD) Q2 Earnings: Disappointment in Store?
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results are likely to benefit from robust laboratory business. However, weak product inspection business remains a concern.
What's in Store for Amphenol (APH) This Earnings Season?
by Zacks Equity Research
Amphenol (APH) is expected to benefit from organic and inorganic growth across most of its end markets in second-quarter 2018 results.
What's in the Cards for Waters Corp (WAT) in Q2 Earnings?
by Zacks Equity Research
Waters Corp (WAT) is scheduled to report second-quarter results which are likely to be driven by its strong position in the pharmaceutical market and robust mass spectrometry portfolio.
Agilent Acquires ULTRA Scientific Assets, Expands Portfolio
by Zacks Equity Research
Agilent (A) recently completes the buyout of the business assets of ULTRA Scientific, thereby expanding its already vast product portfolio.
Agilent (A) to Acquire ProZyme, Expand Glycan Market Share
by Zacks Equity Research
Agilent (A) agrees to acquire glycan analysis company ProZyme for an undisclosed amount.
Agilent (A) Opens Logistics Center, Expands China Foothold
by Zacks Equity Research
Agilent (A) opens a new logistics center in Shanghai to ensure timely delivery of its services in the country.
Agilent Technologies (A) Down 4.5% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent Technologies (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A) Down 2.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent's AATI Acquisition to Strengthen Portfolio, Footprint
by Zacks Equity Research
Agilent (A) is set to acquire AATI, a developer of automated nucleic acid analysis systems using capillary electrophoresis methods, for $250 million.
Agilent (A) Q1 Earnings & Revenues Beat, '18 View Positive
by Zacks Equity Research
Agilent (A) first-quarter fiscal 2018 results benefit from robust top-line growth and improving end-market demand.